May 06, 2026

Texas First for Epioxa Therapy

The first US rollout of FDA-approved epi-on cross-linking aims to improve comfort and recovery for keratoconus patients

The Ophthalmologist

May 01, 2026

Advances in Keratoconus Management

Crosslinking innovation and collaborative care are improving outcomes for patients.

Ophthalmology Management

April 27, 2026

Seeing the Halo

Researchers evaluate a novel optical phenomenon that could expand the clinical value of slit-lamp examination in keratoconus

The Ophthalmologist

April 22, 2026

Permanent J-Code for Epioxa

Glaukos secures permanent J-code from CMS ahead of July rollout

The Ophthalmologist

April 16, 2026

CXL Outcomes Consistent Across Populations

Ethnicity and age show limited impact on cross-linking outcomes for keratoconus

The Ophthalmologist

March 24, 2026

Artificial Tears Reduce Dryness Symptoms in 1-Month Study

Prospective multicenter study without a control group shows symptom scores reduced by more than half after 4 weeks of treatment

Conexiant

February 17, 2026

Corneal Imaging and an ‘Overlooked Source’

Investigators evaluate how iris pigmentation influences Scheimpflug-derived corneal densitometry measurements.

Conexiant

February 12, 2026

HPV Linked to Thyroid Eye Disease

Patients with the eye disorder were more likely to have had low-risk HPV before hyperthyroidism diagnosis.

Conexiant

February 12, 2026

Keratoconus in Hormonal Flux 

Is it time to rethink the importance of hormonal changes on keratoconus pathology?

The Ophthalmologist

January 12, 2026

Personalizing Corneal Cross-Linking

How tailored approaches to CXL are transforming how we treat keratoconus and other corneal ectasias

The Ophthalmologist